Table 1.
Epidemiological and Baseline Clinical Features of 417 Confirmed COVID-19 Patients in the Third People's Hospital of Shenzhen from January 11 to February 18, 2020
Characteristics | COVID-19 Patients |
|||
---|---|---|---|---|
Total (N = 417) | Mild-Moderate (n = 325) | Severe-Critical (n = 92) | p-value | |
Median age (IQR) | 47 (34–60) | 41 (31–56) | 61 (52–65) | <0.001 |
Age subgroups | ||||
0–17 years | 30 (7.2) | 30 (9.2) | 0 | – |
18–60 years | 286 (68.6) | 241 (74.2) | 45 (49) | – |
>60 years | 101 (24.2) | 54 (16.6) | 47 (51) | – |
Male (%) | 198 (47.5) | 139 (42.8) | 59 (64.1) | <0.001 |
BMI (kg/m2) | 23.14 (20.96–25.39) | 22.68 (20.43–24.97) | 24.52 (22.84–26.68) | <0.001 |
Initial symptoms | ||||
Fever | 279 (66.9) | 199 (61.2) | 80 (87.0) | <0.001 |
Cough | 148 (25.5) | 105 (32.3) | 43 (46.7) | 0.015 |
Expectoration | 13 (3.1) | 9 (2.8) | 4 (4.3) | 0.50 |
Headache | 14 (3.4) | 12 (3.7) | 2 (2.2) | 0.74 |
Myalgia | 13 (3.2) | 10 (3.1) | 3 (3.3) | >0.99 |
Chill | 3 (0.7) | 2 (0.6) | 1 (1.1) | 0.53 |
Nausea or vomiting | 1 (0.2) | 1 (0.3) | 0 | >0.99 |
Diarrhea | 11 (2.6) | 7 (2.2) | 4 (4.3) | 0.27 |
Co-existing chronic medical conditions | ||||
Chronic heart disease | 9 (2.2) | 2 (0.6) | 7 (7.6) | <0.001 |
Chronic lung disease | 3 (0.7) | 2 (0.6) | 1 (1.1) | 0.53 |
Chronic renal disease | 6 (1.4) | 2 (0.6) | 4 (4.3) | 0.023 |
Chronic liver disease | 23 (5.5) | 15 (4.6) | 8 (8.7) | 0.21 |
Diabetes | 15 (3.6) | 7 (2.2) | 8 (8.7) | <0.01 |
Hypertension | 23 (5.5) | 13 (4.0) | 10 (10.9) | 0.022 |
Cancer | 1 (0.2) | 0 | 1 (1.1) | 0.22 |
Exposure history | ||||
Traveling history to Hubei | 309 (74.1) | 236 (72.6) | 73 (79.3) | 0.24 |
Interval (days), median (IQR) | ||||
Onset to admission | 3 (1–6) | 3 (1–6) | 4 (2–7) | >0.99 |
Onset to diagnosis | 2 (0–5) | 1 (0–4) | 2 (1–6) | <0.01 |
Bilateral pneumonia | 295 (70.7) | 211 (64.9) | 84 (91.3) | <0.001 |
Unilateral pneumonia | 72 (17.3) | 67 (20.6) | 5 (5.43) | 0.001 |
Values are number (%) except where indicated otherwise. p values indicate differences between mild-moderate and severe-critical patients. p < 0.05 was considered statistically significant.
BMI, body mass index; IQR, interquartile range.